Destiny Wealth Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Destiny Wealth Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.8M	Buy	94,172 +94,136	+261,489%	+$12.7M	1.95%	15
2026 Q1	$4.6K	Buy	+36	New	+$4.49K	﹤0.01%	992
2023 Q1	–	Sell	-758	Closed	-$62.9K	–	657
2022 Q4	$62.9K	Sell	758 -4,038	-84%	-$327K	0.01%	267
2022 Q3	$380K	Hold	4,796	–	–	0.09%	107
2022 Q2	$356K	Hold	4,796	–	–	0.08%	100
2022 Q1	$431K	Sell	4,796 -47,527	-91%	-$4.39M	0.08%	103
2021 Q4	$5.86M	Sell	52,323 -261	-0.5%	-$31.5K	1.13%	34
2021 Q3	$6.61M	Buy	52,584 +3,050	+6%	+$393K	1.33%	25
2021 Q2	$6.71M	Buy	49,534 +3,274	+7%	+$430K	1.28%	25
2021 Q1	$6.28M	Buy	46,260 +5,028	+12%	+$753K	1.31%	26
2020 Q4	$5.8M	Buy	+41,232	New	+$5.28M	1.21%	24

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Destiny Wealth Partners's XBI Position: Q2 2026 in Review

Destiny Wealth Partners increased its State Street SPDR S&P Biotech ETF (XBI) stake by 261,489% in Q2 2026, buying an estimated $12.7M and bringing the position to 94,172 shares worth $13.8M. The position accounts for 1.95% of the portfolio, ranked #15.

Destiny Wealth Partners first reported a position in XBI in Q4 2020 and has held it in 11 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Destiny Wealth Partners held 94,172 shares of State Street SPDR S&P Biotech ETF worth $13.8M as of Q2 2026.
Destiny Wealth Partners bought 94,136 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $12.7M.
State Street SPDR S&P Biotech ETF made up 1.95% of Destiny Wealth Partners's portfolio in Q2 2026, its #15 holding.
Destiny Wealth Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 11 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.